PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Classement en actions #1443
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Prix de l'action
$37.68
Capitalisation boursière
$15.58B
Changement (1 jour)
2.60%
Changement (1 an)
147.72%
Pays
TW
Échange PharmaEssentia Corporation (6446)

Catégorie

Healthcare
Historique des divisions d’actions pour PharmaEssentia Corporation (6446)
L’action PharmaEssentia Corporation (symbole : 6446) a subi un total de 2 divisions.
La division la plus récente a eu lieu le Jul 09, 2026.
Une action 6446 achetée avant le Sep 11, 2025 équivaudrait aujourd’hui à 1.229881 actions 6446.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2026-07-09 1109:1000 x1.109 x1.229881
2025-09-11 1109:1000 x1.109 x1.109
Divisions d’actions d’entreprises similaires ou concurrentes